Corcept Therapeutics Incorporated (CORT)

NASDAQ: CORT · Real-Time Price · USD

33.87

-0.17 (-0.50%)

At close: Mar 6, 2026, 4:00 PM EST

34.54

+0.67 (1.98%)

After-hours: Mar 6, 2026, 7:52 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Discovery, Development and Commercialization of Pharmaceutical Products	761.41M	675.04M	482.38M	401.86M	365.98M
Discovery, Development and Commercialization of Pharmaceutical Products Growth	12.79%	39.94%	20.04%	9.80%	3.42%
Total	761.41M	675.04M	482.38M	401.86M	365.98M
Total Growth	12.79%	39.94%	20.04%	9.80%	3.42%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	761.41M	675.04M	482.38M	401.86M	365.98M
United States Growth	12.79%	39.94%	20.04%	9.80%	3.42%
Total	761.41M	675.04M	482.38M	401.86M	365.98M
Total Growth	12.79%	39.94%	20.04%	9.80%	3.42%

Source: S&P Global Market Intelligence.